Zotefoams PLC Director/PDMR Shareholding (2587Q)
June 04 2018 - 12:50PM
UK Regulatory
TIDMZTF
RNS Number : 2587Q
Zotefoams PLC
04 June 2018
Zotefoams plc
(the 'Company')
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
On 31 May 2018, the Company received notice of exercise and sale
for tax of nil cost options granted over ordinary shares of 5 pence
each ('Shares') under the Company's 2012 Deferred Bonus Share Plan
('DBSP') and 2007 Long-Term Incentive Plan ('LTIP') by Mr D B
Stirling, Chief Executive Officer, as follows:
Director LTIP DBSP Sold for Sale Balance
tax price retained
(GBP)
-------------- ------- ------ --------- -------- ----------
D B Stirling 45,532 8,668 25,526 GBP5.65 28,674
-------------- ------- ------ --------- -------- ----------
Awards granted under the LTIP vest subject to the satisfaction
of performance targets over the three-year performance period. The
level of vesting for awards granted in 2015 was 57.95%, which was
then increased to reflect the dividends paid during the performance
period.
Awards granted under the DBSP vest three years from grant,
subject to satisfaction of service conditions. The awards were
increased to reflect the dividends paid during the restricted
period.
Following these transactions, which took place on 31 May 2018,
Mr Stirling is beneficially interested in the following number of
Shares:
Director Number of % of ISC
Shares(1)
-------------- ----------- ---------
D B Stirling 446,193 0.92%
-------------- ----------- ---------
(1) Includes Partnership Shares, Dividend Shares and vested
Matching Shares under the Company's Share Incentive Plan.
The Notification of Dealing Form for Mr Stirling can be found
below.
This notification is made in accordance with the Market Abuse
Regulation.
Enquiries:
Alex Small
Group Company Secretary
Zotefoams plc
04 June 2018
020 8664 1600
About Zotefoams plc:
Zotefoams plc (LSE - ZTF) is a world leader in cellular
materials technology. Using a unique manufacturing process with
environmentally friendly nitrogen expansion, Zotefoams produces and
sells lightweight AZOTE(R) polyolefin and ZOTEK(R) high-performance
foams for diverse markets worldwide. Zotefoams uses its own
cellular materials to manufacture T-FIT(R) advanced insulation for
demanding industrial markets. In addition, Zotefoams owns and
licenses patented MuCell(R) microcellular foam technology,
developed specifically for extrusion applications, from a base in
Massachusetts, USA to customers worldwide.
Zotefoams is headquartered in Croydon, UK, with additional
manufacturing sites in Kentucky and Oklahoma, USA (foam products
manufacture and conversion), Massachusetts, USA (MuCell Extrusion)
and Jiangsu Province, China (T-FIT(R)).
www.zotefoams.com
AZOTE(R), ZOTEK(R), T-FIT(R) are registered trademarks of
Zotefoams plc
MuCell(R) is a registered trademark of Trexel Inc.
ZOTEFOAMS PLC
DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND
THEIR CLOSELY ASSOCIATED PERSONS
1. Details of the person discharging managerial
responsibilities/person closely associated
--- --------------------------------------------------
a) Name: David Stirling
--- --------------------------------------------------
2. Reason for the notification
--- --------------------------------------------------
a) Position/status: Group CEO
--- --------------------------------------------------
b) Initial notification/Amendment: Initial
notification
--- --------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- --------------------------------------------------
a) Name: Zotefoams plc
--- --------------------------------------------------
b) LEI: 213800B6P256B5XN8D32
--- --------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- --------------------------------------------------
a) Description of the financial instrument,
type of instrument:
Ordinary shares of 5 pence each
Identification code: GB0009896605
--- --------------------------------------------------
b) Nature of the transaction: Exercise and
retention under the Long-Term Incentive
Plan
--- --------------------------------------------------
c) Price(s) and volume(s): Price(s) Volume(s)
---------- ----------
GBP0.00 24,090
---------- ----------
--- --------------------------------------------------
d) Aggregated information:
Aggregate Aggregate Aggregate
Price Volume Total
---------- ---------- ----------
GBP0.00 24,090 GBP0.00
---------- ---------- ----------
--- --------------------------------------------------
e) Date of the transaction: 31 May 2018
--- --------------------------------------------------
f) Place of the transaction: XLON
--- --------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- --------------------------------------------------
a) Description of the financial instrument,
type of instrument:
Ordinary shares of 5 pence each
Identification code: GB0009896605
--- --------------------------------------------------
b) Nature of the transaction: Exercise and
sale under the Long-Term Incentive Plan
to pay the tax liability.
--- --------------------------------------------------
c) Price(s) and volume(s): Price(s) Volume(s)
---------- ----------
GBP5.65 21,442
---------- ----------
--- --------------------------------------------------
d) Aggregated information:
Aggregate Aggregate
Price Volume
--------------- ----------
GBP121,147.30 21,442
--------------- ----------
--- --------------------------------------------------
e) Date of the transaction: 31 May 2018
--- --------------------------------------------------
f) Place of the transaction: XLON
--- --------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------
a) Description of the financial instrument,
type of instrument:
Ordinary shares of 5 pence each
Identification code: GB0009896605
--- -------------------------------------------------
b) Nature of the transaction: Exercise and
retention under Deferred Bonus Share Plan
--- -------------------------------------------------
c) Price(s) and volume(s): Price(s) Volume(s)
---------- ----------
GBP0.00 4,584
---------- ----------
--- -------------------------------------------------
d) Aggregated information:
Aggregate Aggregate
Price Volume
----------- ----------
GBP0.00 4,584
----------- ----------
--- -------------------------------------------------
e) Date of the transaction: 31 May 2018
--- -------------------------------------------------
f) Place of the transaction: XLON
--- -------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------
a) Description of the financial instrument,
type of instrument:
Ordinary shares of 5 pence each
Identification code: GB0009896605
--- -------------------------------------------------
b) Nature of the transaction: Exercise and
sale for tax under Deferred Bonus Share
Plan
--- -------------------------------------------------
c) Price(s) and volume(s): Price(s) Volume(s)
---------- ----------
GBP5.65 4,084
---------- ----------
--- -------------------------------------------------
d) Aggregated information:
Aggregate Aggregate
Price Volume
-------------- ----------
GBP23,076.60 4,084
-------------- ----------
--- -------------------------------------------------
e) Date of the transaction: 31 May 2018
--- -------------------------------------------------
f) Place of the transaction: XLON
--- -------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHEAKKLELXPEFF
(END) Dow Jones Newswires
June 04, 2018 12:50 ET (16:50 GMT)
Zotefoams (LSE:ZTF)
Historical Stock Chart
From Feb 2024 to Mar 2024
Zotefoams (LSE:ZTF)
Historical Stock Chart
From Mar 2023 to Mar 2024